SCLERODERMA RENAL CRISIS AS A POSSIBLE COMPLICATION OF CYCLOSPORINE-A WITHDRAWAL

被引：7

作者：

CASOLI, P

CARRETTI, C

TUMIATI, B

机构：

[1] 2nd Department of Medicine, Ospedale S. Maria Nuova, Reggio Emilia

来源：

CLINICAL RHEUMATOLOGY | 1994年 / 13卷 / 01期

关键词：

SYSTEMIC SCLEROSIS; CYCLOSPORINE-A; SCLERODERMAL RENAL CRISIS;

D O I：

10.1007/BF02229882

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The pharmacological treatment of systemic sclerosis (SSc) has been discouraging. In view of this, therapeutic trials with cyclosporine A (CyA) are outstanding particularly in patients with a rapid cutaneous involvement. We report the case of a patient whose SSc cutaneous manifestations dramatically improved with CyA therapy. Its subsequent withdrawal led to a quick onset of a fatal sclerodermal renal crisis. We believe that in our patient there could have been a cause and effect relationship between the suspension of CyA and kidney sclerodermal complication.

引用

页码：126 / 128

页数：3

共 21 条

[1]

Steigerwald J.C., Progressive systemic sclerosis: Management III. Immunosuppressive agents, Clin Rheum Dis, 5, pp. 289-294, (1979)

[2]

DeClerck L.S., Dequeker J., Francx L., Demedts M., D-penicillamine therapy and interstitial lung disease in scleroderma: a long term follow-up study, Arthritis Rheum, 30, pp. 643-650, (1987)

[3]

Sattar M.A., Guindi R.T., Sugathan T.N., Penicillamine in systemic sclerosis: a reappraisal, Clin Rheum, 9, pp. 517-522, (1990)

[4]

Zarafonetis C.J.D., Anti-fibrotic therapy with potaba, Am J Med Sci, 248, pp. 550-561, (1964)

[5]

Alarcon-Segovia D., Ramos-Nieo F., Ibanez de Kasep G., Alcocer J., Parez Tamato R., Long evaluation of colchicine in the treatment of scleroderma, J Rheum, 6, pp. 705-712, (1979)

[6]

Zachariae H., Halkier-Sorensen L., Heickendorff L., Zachariae E., Hansen H.E., Cyclosporine A treatment of systemic sclerosis, Br J Dermatol, 122, pp. 677-681, (1990)

[7]

Gisslinger H., Burghuber O.C., Stacher G., Schwarz W., Punzengruber C., Ganinger W., Luger T.A., Wolff K., Smolen J.S., Efficacy of cyclosporine A in systemic sclerosis, Clin Exp Rheum, 9, pp. 383-990, (1991)

[8]

Steen V.D., Medsger T.A., Rodnam J.P., D-Penicillamine therapy in progressive systemic sclerosis (scleroderma). A retrospective analysis, Ann Int Med, 9, pp. 652-659, (1982)

[9]

Steen V.D., Costantino J.P., Shapiro A.P., Medsger T.A., Outcome of renal crisis in systemic sclerosis: Relation to availability of angiotensin converting enzyme (ACE) inhibitors, Ann Intern med, 113, pp. 352-357, (1990)

[10]

Porter G.A., Bennett W.M., Sheps S.G., Cyclosporine-associated hypertension, Arch Intern Med, 150, pp. 280-283, (1990)

← 1 2 3 →